Oral Drug Delivery Resources
-
Formulation Research Strategy For Discovery- Stage New Drug Candidates
1/24/2022
Early stage formulation studies, which should support the emerging target product profile, will often yield important experimental results to aid subsequent development of clinically relevant dosage forms.
-
A Solvent-Free, Fusion-Based ASD Manufacturing Process
3/5/2024
Explore a solvent-free alternative for the production of amorphous solid dispersions (ASDs) that not only improves manufacturability but also reduces the carbon footprint of ASD manufacturing.
-
Steps To Overcome Challenges Associated With Biologic Formulation Development
8/24/2022
Explore guidance on the challenges posed by biologics, including overcoming degradation, establishing a stress test process, and the value of lipid nanoparticles (LNPs) and polymeric nanoparticles (NPs).
-
Inspiring A New Era Of Patient-Centric Medicines
3/23/2023
Patients are more empowered, making it essential to promote better adherence, improve medical benefits, and bolster market perception. See the technologies enabling this shift toward patient-centricity.
-
High Potent Formulation Development In Oncology
6/1/2023
Examine the vital role formulation development plays in oncology outsourcing and how sponsors can increase their chances of success with the right CDMO partner.
-
Advances In Spray Drying For Enhanced Bioavailability And Improved Formulation Control
In a recent webinar, Lonza discussed the process it uses to develop a spray dried powder formulation and scale from early feasibility studies to manufacturing.
-
Pharmaceutical Nanotechnology: What To Know
8/10/2022
Here is what you need to know about the key advantages that pharmaceutical nanotechnology provides in improving drug efficacy and decreasing adverse reactions.
-
A Taste Masked And Easily Swallowed Malaria Drug For Elderly Patients
4/20/2023
Dysphagia impacts treatment compliance and disproportionately affects the elderly. Learn how microencapsulation enabled formulation of a water-soluble powder drives patient adherence.
-
Harness High-Quality PBPK Modeling To Enhance Clinical Readiness
Physiologically based pharmacokinetic (PBPK) modeling advancements are helping drug sponsors mitigate risk in preclinical and clinical studies through early identification of poor absorption properties.
-
Liposome Vs. Lipid Nanoparticle: What's The Difference?
8/10/2022
Here, we discuss the differences between nanoparticles and liposomes along with their applications in medicine.